Idiopathic thrombocytopenic purpura in childhood

Pediatric Annals

Volumn 30, Issue 9, 2001, Pages 527-533

  Buchanan, G R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; IBUPROFEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN D ANTIBODY; METHYLPREDNISOLONE; PREDNISONE;

CHILD; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PATHOGENESIS; PRACTICE GUIDELINE; REVIEW; SPLENECTOMY;

EID: 0034751767     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20010901-07     Document Type: Review

References (16)

1. Current controversies in the management of idiopathic thrombocytopenic purpura during childhood
2. Intracranial hemorrhage in idiopathic thrombocytopenic purpura
3. Management of childhood idiopathic thrombocytopenic purpura
4. Idiopathic thrombocytopenic purpura
5. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura
6. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura
7. Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G
8. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients
9. Idiopathic thrombocytopenic purpura: Beyond consensus
10. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment
11. Outcome measures and treatment endpoints other than platelet count in childhood idiopathic thrombocytopenic purpura
12. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis
13. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy
14. Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura
15. Elective splenectomy in children with idiopathic thrombocytopenic purpura
16. Comparison of laparoscopic and open splenectomy in children with hematologic disorders